Search
for

    Sort by

    Research 30 of 1000+

    1. Mesenchymal Stem Cells Antagonize IFN-Induced Proinflammatory Changes and Growth Inhibition Effects via Wnt/β-Catenin and JAK/STAT Pathway in Human Outer Root Sheath Cells and Hair Follicles International journal of molecular sciences · 2021 · 14 citations
    2. An overview of JAK/STAT pathways and JAK inhibition in alopecia areata Frontiers in immunology · 2022 · 40 citations
    3. Ruxolitinib reverses alopecia areata via a triple mechanism: JAK-STAT inhibition, localized oxidative stress attenuation and selective apoptosis modulation Journal of Translational Autoimmunity · 2026
    4. Pharmacologic inhibition of JAK-STAT signaling promotes hair growth Science Advances · 2015 · 159 citations
    5. Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus Annals of the rheumatic diseases · 2020 · 16 citations
    6. APECED: JAK Inhibition in an Adult Case with Long-Term Follow-up Journal of Human Immunity · 2025
    7. Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells Cells · 2019 · 51 citations
    8. Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway Indian Dermatology Online Journal · 2023
    9. Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib Acta Dermato Venereologica · 2020 · 13 citations
    10. Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo Current dermatology reports · 2017
    11. 681 Inhibition of STAT3, using Oenocarpus bataua vegetable oil, on in vitro model Journal of Investigative Dermatology · 2016
    12. Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima Processes · 2020 · 15 citations
    13. Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model Journal of Investigative Dermatology · 2026
    14. Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors? Pediatric dermatology · 2018 · 11 citations
    15. The Effect of JAK Inhibitor on the Survival, Anagen Re-Entry, and Hair Follicle Immune Privilege Restoration in Human Dermal Papilla Cells International Journal of Molecular Sciences · 2020 · 16 citations
    16. Montagna Symposium 2017—Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment 2018 · 1 citations
    17. Small Molecule Inhibitors and Inflammatory Skin Diseases Suez Canal University Medical Journal · 2018
    18. Alopecia universalis successfully treated with tofacitinib Journal of the American Academy of Dermatology · 2017 · 2 citations
    19. Unexpected Effect of Baricitinib Use: Observation of a Case of Hypertrichosis Indian Journal of Dermatology · 2026
    20. Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib JAAD Case Reports · 2024
    21. Concomitant management of alopecia universalis and ulcerative colitis with upadacitinib Internal Medicine Journal · 2024 · 2 citations
    22. Topical Ruxolitinib in Combination with Oral Minoxidil Results in Hair Regrowth in a Patient with Central Centrifugal Cicatricial Alopecia and Concomitant Traction Alopecia JAAD Case Reports · 2025
    23. Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata Rheumatology · 2022 · 3 citations
    24. Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes Journal of Investigative Dermatology · 2022
    25. Unexpected Extensive Hair Whitening Following Baricitinib Treatment for Alopecia Universalis: A Case Report and Mechanistic Insights Cureus · 2024
    26. Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata Journal of Cosmetic Dermatology · 2025
    27. Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date Drugs in context · 2023
    28. Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib Anais Brasileiros de Dermatologia · 2026
    29. Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review Frontiers in Immunology · 2026
    30. 700 Oncostatin M is upstream of JAK-STAT signaling during the murine hair cycle Journal of Investigative Dermatology · 2016